miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 6, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1038/s41419-018-0698-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
- (2017) Lisa Koetz-Ploch et al. Pigment Cell & Melanoma Research
- Novel miR-5582-5p functions as a tumor suppressor by inducing apoptosis and cell cycle arrest in cancer cells through direct targeting of GAB1, SHC1, and CDK2
- (2016) Hyun-Ju An et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
- (2016) Min Hwan Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hsa-miR-132 inhibits proliferation of hepatic carcinoma cells by targeting YAP
- (2015) Chang-Jiang Lei et al. CELL BIOCHEMISTRY AND FUNCTION
- MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer
- (2015) Chongbiao Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
- (2015) M. H. Kim et al. EMBO JOURNAL
- The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
- (2015) Luping Lin et al. NATURE GENETICS
- DIANA-miRPath v3.0: deciphering microRNA function with experimental support
- (2015) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR
- (2014) Yue Wang et al. ACTA PHARMACOLOGICA SINICA
- MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma
- (2014) Zhaoli Chen et al. CANCER LETTERS
- Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties
- (2014) S. Song et al. CANCER RESEARCH
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
- (2014) Masaki Mori et al. CELL
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- CIP2A Modulates Cell-Cycle Progression in Human Cancer Cells by Regulating the Stability and Activity of Plk1
- (2013) J.-S. Kim et al. CANCER RESEARCH
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
- (2012) Karen Tumaneng et al. NATURE CELL BIOLOGY
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
- (2011) H. Yang et al. CANCER RESEARCH
- Resistance to BRAF Inhibitors: Unraveling Mechanisms and Future Treatment Options
- (2011) J. Villanueva et al. CANCER RESEARCH
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- (2011) Michela Garofalo et al. NATURE MEDICINE
- MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties
- (2010) Angela M. Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
- (2009) R. N. Jorissen et al. CLINICAL CANCER RESEARCH
- Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
- (2009) J. Joshua Smith et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started